INSIGHTS ON QUALITY CONTROL

• CDMO Audit Coverage: Key Focus Areas And Compliance Objectives

  CDMO audits focus on compliance, quality, performance, and relationships to reduce risk, ensure clear documentation, and align customer expectations with CDMO capabilities.

• Method Migration Of A Normal Phase HPLC Method For Tocopherols

  The ability to migrate methods across HPLC systems is essential as systems are updated. Review a normal phase method that provides a means for quantification of tocopherols in vitamin supplements.

• Innovative Technology For Developing, Scaling Peptide-Based Therapeutics

  Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.

• The Role Of Quality By Design In Pharmaceutical Tablet Development

  Quality by Design (QbD) ensures efficiency and high standards in pharmaceutical tablet development. Explore how this proactive approach transforms manufacturing processes and enhances product quality.

• A Closer Look At Multi-Lane Checkweighing In Pharma

  5/2/2025

  Learn how multi-lane checkweighing boosts operational efficiency, ensures accurate dosing, and simplifies changeovers, making it ideal for applications like dual-chamber sachets and nutraceutical products.

• Seamlessly Integrating An E-WorkBook With A Customer's LIMS

  8/12/2024

  Explore the story of a global biopharma company's integration of E-WorkBook with their LIMS, automating ADA study reports, saving significant time, and enhancing data accuracy.

• Next-Gen Medium And Feeds System To Improve CHO Cell Line Productivity

  6/19/2024

  Choose the right CHO medium and feed system to optimize your upstream processes and secure a seamless scaling up.

• How LIMS Supports QC Scaling At Forge Biologics

  1/21/2026

  Modernizing QC workflows with cloud-based systems eliminates paper inefficiencies, reduces errors, and accelerates reporting. Discover how streamlined processes improve compliance and enhance data visibility.

• Understanding cGMPs For Phase 1 Investigational Drugs

  8/15/2025

  Learn how a structured, risk-based approach to early-phase manufacturing can help streamline processes, reduce costs, and accelerate the path to first-in-human trials while meeting FDA cGMP guidelines.